T1D-Plus study with Dexcom
The procurement contact named on the official notice.
T1D-Plus trial is a randomised, adaptive, open label, parallel group, multi-centre Platform trial in adults with newly diagnosed type 1 diabetes).
The T1D Plus trial, funded by JDRF, sponsored by CU, started on 30th September 2022, led by Colin Dayan.
Since that time, additional arms of the trial have been funded by separate grants from the Helmsley Charitable Trust and JDRF Australia.
Funding was agreed in Dec 2023.
An endpoint in the trial is the recording of glucose levels by a continuous glucose monitoring device.
These devices are marketed by different companies with different specifications.
Make the case to bid
Reveal who to approach at CARDIFF UNIVERSITY, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- ocds-h6vhtk-060896
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 004296-2026
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
CARDIFF UNIVERSITY’s tender network
Assembling the network…